THIS PPT IS ABOUT THE HEALTH CARE SYSTEM IN CHINA MOSTLY STUDIED IN ECONOMICS.
THIS ALSO SHOWS YOU ABOUT THE INSURANCE POLICY AND GDP RATE AND MANY MORE
The People’s Republic of China has made great achievements in improving health status over the past six decades, mainly due to the government’s commitment to health, provision of cost effective public health programmes, growing coverage of health financial protection mechanisms and investments in an extensive health-care delivery network.
Healthcare is a major part of every country's development platform. By healthcare we are in fact protecting the most important driver of development. Healthcare systems are primarily safe guarding the development core engine and are the best means of sustainable development.
Understanding the concept of Universal Health Coverage (UHC) and how can we reach it, both globally and also in India. The presentation also includes HLEG report , which is the proposed architecture for India's guide to reach UHC.
The People’s Republic of China has made great achievements in improving health status over the past six decades, mainly due to the government’s commitment to health, provision of cost effective public health programmes, growing coverage of health financial protection mechanisms and investments in an extensive health-care delivery network.
Healthcare is a major part of every country's development platform. By healthcare we are in fact protecting the most important driver of development. Healthcare systems are primarily safe guarding the development core engine and are the best means of sustainable development.
Understanding the concept of Universal Health Coverage (UHC) and how can we reach it, both globally and also in India. The presentation also includes HLEG report , which is the proposed architecture for India's guide to reach UHC.
Effect of globalization on health care meghadevgan3
Globalization is characterized by the circulation of goods and services between countries using the criteria of efficiency.
The direct health effects of globalization has not been yet observed but there are factors which may influence this phenomenon the further discussion of the impacts is given under following:
Circulation of Patients
Circulation of Health Professionals
International Accreditation System
Health economics is a branch of economics concerned with issues related to efficiency, effectiveness, value and behavior in the production and consumption of health and healthcare.
This is the product of compilation from various sources. I would like to acknowledge all direct and indirect sources although they have not been mentioned explicitly within the document.
This slide contains a overview of Grossman Model . which includes concept of health as a human capital, little bit biography of michael grossman and his model and application of that model
Universal Health Coverage (UHC) Day 12.12.14, NepalDeepak Karki
This presentation is made on the first ever Universal Health Coverage (UHC) Day 12.12.14 celebration in Nepal by Nepal Health Economics Association (NHEA).
Roadmap for Universal Health Care. FDR, PHFI, and Loksatta are convening a Roundtable of experts, thinkers and practitioners to have a purposive dialogue and help evolve a viable, effective model of universal healthcare delivery in India
Effect of globalization on health care meghadevgan3
Globalization is characterized by the circulation of goods and services between countries using the criteria of efficiency.
The direct health effects of globalization has not been yet observed but there are factors which may influence this phenomenon the further discussion of the impacts is given under following:
Circulation of Patients
Circulation of Health Professionals
International Accreditation System
Health economics is a branch of economics concerned with issues related to efficiency, effectiveness, value and behavior in the production and consumption of health and healthcare.
This is the product of compilation from various sources. I would like to acknowledge all direct and indirect sources although they have not been mentioned explicitly within the document.
This slide contains a overview of Grossman Model . which includes concept of health as a human capital, little bit biography of michael grossman and his model and application of that model
Universal Health Coverage (UHC) Day 12.12.14, NepalDeepak Karki
This presentation is made on the first ever Universal Health Coverage (UHC) Day 12.12.14 celebration in Nepal by Nepal Health Economics Association (NHEA).
Roadmap for Universal Health Care. FDR, PHFI, and Loksatta are convening a Roundtable of experts, thinkers and practitioners to have a purposive dialogue and help evolve a viable, effective model of universal healthcare delivery in India
Presented at “Financial Protection and Improved Access to Health Care: Peer-to-Peer Learning Workshop Finding Solutions to Common Challenges” in Accra, Ghana, February 2016. To learn more, visit: https://www.hfgproject.org/ghana-uhc-workshop
This presentation is about Healthcare delivery system in China which includes, the demographic features of China and India, how the China's healthcare started with the historical background, Its health reforms, and the newly formed health infrastructure and the programs. Download the powerpoint to visualize the animation included in the slide.
Universal health coverage was established in the WHO constitution of 1948 declaring health a fundamental human right.The goal of universal health coverage is to ensure that all people obtain the health services they need without suffering financial hardship when paying for them.
A health system, also sometimes referred to as health care system, is the organization of people, institutions, and resources that deliver health care services to meet the health needs of target populations.
Health systems are responsible for delivering services that improve, maintain or restore the health of individuals and their communities.
Common elements in virtually all health systems are primary healthcare and public health measures.
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
The Importance of Community Nursing Care.pdfAD Healthcare
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
3. STATISTICS
Total population (2016) 1,379,000,000
Gross national income per
capita (PPP international $,
2013)
11,000
Life expectancy at birth m/f
(years, 2016)
75/78
Probability of dying under
five (per 1 000 live births, 0)
not available
Probability of dying between
15 and 60 years m/f (per 1
000 population, 2016)
93/67
Total expenditure on health
per capita (Intl $, 2014)
731
Total expenditure on health
as % of GDP (2014)
5.5
11. SRUCTURE OF HEALTH CARE SYSTEM
• The Chinese healthcare system is organized into three tiers of increasing intensity
of care. With primary care facilities in villages or towns as the first tier, county
hospitals as the second tier, and tertiary hospitals, usually located in major cities.
• As a patients visit facilities on higher tiers, their copayments often increase by
orders of magnitude for each tier. This can lead patients to fail to seek out
necessary treatment.
12. • The Chinese healthcare system is overseen by the Health and Family
Planning Commission to ensure fair healthcare across all of china, however
with 45% of hospitals privately owned and mainly for-profit, quality of care
and professionalism can vary (The Commonwealth Fund).
• The majority of Chinese hospital profits come from prescriptions, which are
often not covered by the general government provided health insurance.
Hospitals are allowed a 15% markup in distribution of prescription drugs,
giving providers financial incentive to generate demand for more
expensive drugs (The Commonwealth Fund).
13. GOVERNANCE OF HEALTH CARE SYSTEM
• In 2013, the Ministry of Health and the National Population and Family Planning Commission were merged
into the National Health and Family Planning Commission as the main agency for health controlled by the
State Council. The State Administration of Traditional Chinese Medicine is affiliated with the new agency. The
National People’s Congress is responsible for health legislation. However, major health policies and reforms
may be initiated by the State Council and the Central Committee of the Communist Party as well, and these
are also regarded as law.
• The National Health and Family Planning Commission directly owns some hospitals in Beijing, and national
universities directly administrated by the Ministry of Education also own affiliated hospitals. Local government
health agencies, usually the Bureau of Health or the Health and Family Planning Commission in each province,
may have a similar structure and often own provincial hospitals. Local governments (of prefectures, counties,
and towns) may have departments of health and own hospitals directly. Centers for disease control and
prevention also exist in local areas and are administered by the local bureaus or departments of health. At the
national level, the China Center for Disease Control and Prevention provides only technical support to the local
centers.
15. • Publicly financed health insurance: In 2014, China spent approximately 5.6 percent of its gross
domestic product (CNY3,531 billion, or USD992 billion) on health care, with 30 percent financed by the
central government and local governments and 38 percent by publicly financed health insurance, private
health insurance, or social health donations.
• There were three main types of publicly financed insurance:
1. urban employment-based basic medical insurance (launched in 1998)
2. urban resident basic medical insurance (launched in 2009)
3. the “new cooperative medical scheme” for rural residents (launched in 2003).
Urban employment-based basic medical insurance is financed mainly from employee and employer
payroll taxes, with minimal government funding. Participation is mandatory for employees in urban areas
Urban resident basic medical insurance, which is voluntary at the household level, covered 314.5
million self-employed individuals, children, students, and elderly adults in 2014.
16. Both urban employment-based and urban resident basic medical insurance are administered by the
Ministry of Human Resources and Social Security and run by local authorities. The rural new
cooperative medical scheme, administered mainly by the National Health and Family Planning
Commission and run by local authorities, is also voluntary at the household level.
Private health insurance: Complementary private health insurance is purchased to cover deductibles,
copayments, and other cost-sharing, as well as coverage gaps, in publicly financed health insurance,
which serves as the primary coverage source for most people. Private health insurance is also called
commercial health insurance, because it is provided mainly by for-profit commercial insurance
companies.
17. INSURANCE OF POPULATION
• Publicly financed insurance covers primary, specialist, emergency department, hospital, and mental health
care, as well as prescription drugs and traditional medicine. A few dental services (e.g., tooth extraction,
but not cleaning) and optometry services are covered, but mostly such services are paid for completely
out-of-pocket.
• Most out-of-pocket spending is for prescription drugs. Reimbursement ceilings are significantly lower for
outpatient care than for inpatient care. For example, in 2016, ceilings were CNY3,000 (USD843) for
outpatient care in primary care facilities, CNY10,000 (USD2,809) for outpatient care in secondary/tertiary
hospitals, and CNY180,000 (USD50,562) for outpatient care in the rural new cooperative medical scheme in
Beijing.
SHANGHAI HEALTH
INSURANCE CARD
18. • For individuals who are not able to afford individual premiums for publicly financed health
insurance or who cannot cover out-of-pocket spending (which is not capped), a medical
financial assistance program, funded by local governments and social donations, serves as a
safety net in both urban and rural areas.
• Medical financial assistance programs prioritize inpatient care expenses. Funds are used mainly to pay
for individual deductibles, copayments, and medical spending exceeding annual caps, as well as
individual premiums for publicly financed health insurance. In 2014, 67.2 million people (approximately
5% of the Chinese population) received such assistance for health insurance enrollment, and 24.0
million people (1.8% of the population) received funds for direct health expenses.
• There are other financial assistance programs to help with unreimbursed emergency department and
other health expenses. These are funded mostly by local governments.
20. Problems in China’s health system
Lack of stable budget resources
Great variability in ability to pay by employers
Casual attitudes towards medical expenditure
Incompatible with new ownership structure
Deferred payment causes resentment and social problems
21. CONCLUSION
• China has now achieved universal coverage, since 1.295 out of 1.3397 billion people
— fully 95% of the population — have health insurance, and out-of-pocket
spending is 35.5% of total expenditure on health.
• However, the government hails this triumph of risk pooling not as universal
coverage but as achieving the interim goal of expanding basic coverage articulated
in the 2009 reform plan.
• The system continues to have many weaknesses in providing access to quality
services.
• The challenge is to continue to deepen risk pooling, strengthen primary care, raise
clinical quality, improve incentives, and re-engineer service delivery to better fit the
needs of China’s increasingly urban, affluent, and aging society.